$Anti-GAD65 Antibodies Related Refractory Epilepsy Successfully Treated with Tocilizumab: A Case Report and Systematic Literature Review$

Anti-GAD65 Antibodies Related Refractory Epilepsy Successfully Treated with Tocilizumab: A Case Report and Systematic Literature Review

Shimeng Chen,1 Miriam Kessi,1 Jielu Tan,1– 3 Fang He,1– 3 Ciliu Zhang,1– 3 Fei Yin,1– 3 Lifen Yang,1– 3 Jing Peng1– 3 1Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, People’s Republic of China; 2Hunan Intellectual and Developmental Disabilities Research Center, Pedia...

Full description

Saved in:

Bibliographic Details
Main Authors:	Chen S, Kessi M, Tan J, He F, Zhang C, Yin F, Yang L, Peng J
Format:	Article
Language:	English
Published:	Dove Medical Press 2025-04-01
Series:	ImmunoTargets and Therapy
Subjects:	anti-gad65 autoantibodies epilepsy tocilizumab efficacy safety review
Online Access:	https://www.dovepress.com/anti-gad65-antibodies-related-refractory-epilepsy-successfully-treated-peer-reviewed-fulltext-article-ITT
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Autoimmune Encephalitis and Musicogenic Epilepsy: A Case of GAD65 Antibody‐Associated Seizure
by: Ali Mohammadi‐Asl, et al.
Published: (2025-05-01)

Probable Anti-Glutamate Decarboxylase 65 (Gad65) Antibody-Associated Cerebellar Ataxia. Clinical Case Report and Literature Review
by: J. Valinčiūtė, et al.
Published: (2023-11-01)

GAD65-positive autoimmune-associated epilepsy presenting with Ictal Hand Kissing; an uncommon presentation of a rare disease
by: Alia M.R. Fallatah, et al.
Published: (2025-09-01)

Anti‐GAD65 musicogenic epilepsy: Bilateral and independent mesial temporal seizures revealed by foramen ovale electrodes
by: Roberta Di Giacomo, et al.
Published: (2025-04-01)

Coexistence of CN1A autoantibodies in GAD65 encephalitis exacerbates neurodegeneration
by: Annika Breuer, et al.
Published: (2025-07-01)

Uncommon Pediatric Immune-Mediated Epilepsy: Disease Course, Diagnosis, and Outcome – A Series of Three Cases
by: Aakash Mahesan, et al.
Published: (2024-10-01)

Prevalence of Autoantibodies in Type 1 Diabetes Mellitus and the Clinical Utility of Diabetes Antibody Testing in the Indian Population: A Retrospective Study of 3 Years
by: Flavia Almeida, et al.
Published: (2024-03-01)

Prevalence of Latent Autoimmune Diabetes of Adult (LADA) among Type2 Diabetes Mellitus (D.M.2) in Karbala
by: Sawsan M. AL-Hasnawi, et al.
Published: (2015-04-01)

Limbic autoimmune encephalitis with antibodies to glutamate decarboxylase (GAD)
by: L. U. Ulukhanova, et al.
Published: (2020-06-01)

EFFICACY AND SAFETY OF TOCILIZUMAB IN CHILDREN WITH SYSTEMIC JUVENILE ARTHRITIS IN CLINICAL PRACTICE
by: M. I. Kaleda, et al.
Published: (2015-04-01)

Betatrophin: A promising biomarker for metabolic syndrome and diabetes mellitus risk screening in teenagers
by: Hendra Susanto, et al.
Published: (2025-04-01)

Pediatric Case of Autoimmune Cerebellitis with Positive Anti-GAD Antibodies and Accidental Finding of Roth Spots
by: Hajatmena Alkhedir, et al.
Published: (2024-07-01)

Coexistence of Anti-GAD and Anti-GABAAR Antibodies in an Autoimmune Encephalitis Patient: A Case Report
by: Lu X, et al.
Published: (2025-01-01)

Prospects of antigen-specific therapy in type 1 diabetes mellitus
by: Tatiana Vasil'evna Nikonova, et al.
Published: (2012-12-01)

Persistent effect of tocilizumab in refractory Takayasu’s arteritis (clinical observation)
by: G. M. Koilubaeva, et al.
Published: (2022-05-01)

Treating Systemic Juvenile Idiopathic Arthritis with Tocilizumab: Clinical Case
by: E. I. Alekseeva, et al.
Published: (2016-11-01)

NEUROIMMUNOPATHOGENIC MECHANISMS OF EPILEPSY
by: Yо. N. Madjidova, et al.
Published: (2016-05-01)

RAPID EFFECT OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS
by: E Yu Panasyuk, et al.
Published: (2011-08-01)

Efficacy of tocilizumab in resistant forms of Thyroid Eye Disease
by: Marković Bojan, et al.
Published: (2025-01-01)

Progressive encephalomyelitis with rigidity and myoclonus after thymectomy in a woman with myasthenia gravis
by: Lixia Qin, et al.
Published: (2025-04-01)

Analysis of Early EEG Changes After Tocilizumab Treatment in New-Onset Refractory Status Epilepticus
by: Yong-Won Shin, et al.
Published: (2025-06-01)

Tocilizumab as a targeted immunomodulatory therapy in the management of severe respiratory illnesses: a multicenter cohort study of COVID-19 patients
by: Abbas Al Mutair, et al.
Published: (2025-07-01)

Success Treatment of Severe and Active Graves’ Orbitopathy with Tocilizumab After Thyroidectomy and Maximum Dose of Intravenous Methylprednisolone
by: Laurentius Aswin Pramono
Published: (2024-01-01)

Estrategias TIC para la optimización de la gestión financiera en los GADs: una revisión de la literatura
by: Tito Santiago Bustamante-Ordoñez, et al.
Published: (2025-04-01)

Extracellular vesicle GABA responds to cadmium stress, and GAD overexpression alleviates cadmium damage in duckweed
by: Zhanpeng Sun, et al.
Published: (2025-03-01)

The Promising Effect of Tocilizumab on Chronic Antibody-Mediated Rejection (cAMR) of Kidney Transplant
by: Łukasz Świątek, et al.
Published: (2025-01-01)

A CASE REPORT OF THE USE TOCILIZUMAB IN REFRACTORY SYSTEMIC JUVENILE ARTHRITIS WITH PULMONARY INVOLVEMENT AND MACROPHAGE ACTIVATION SYNDROME
by: M. I. Kaleda, et al.
Published: (2015-09-01)

PROSPECTS FOR USING TOCILIZUMAB IN SYSTEMIC SCLEROSIS
by: L. P. Ananyeva
Published: (2016-02-01)

Prevalence of Anxiety and Depressive Disorders in a Sample of Moscow Residents: Comparison of the GAD-7 and HADS Results with a Clinical Assessment
by: Valeriya I. Savenkova, et al.
Published: (2024-12-01)

Tocilizumab combined with cyclophosphamide for the treatment of rapidly progressive refractory systemic sclerosis with predominant cardiac involvement: a case report
by: Zhong-Chao Fu, et al.
Published: (2025-07-01)

La vinculación del GAD municipal con la comunidad: un análisis profundo de la literatura
by: Eddy Patricio Erraez-Donaula, et al.
Published: (2025-03-01)

A comparative study of anxiety symptoms in Chinese and Rwandan adolescents: a cross-cultural measurement invariance study of the GAD-7 scale
by: Lisa Cynthia Niwenahisemo, et al.
Published: (2025-05-01)

Tocilizumab: A potent immunomodulatory agent in the treatment of COVID-19 pneumonia
by: Sameer Bansal, et al.
Published: (2021-01-01)

COMPARATIVE EVALUATION OF THE EFFICIENCY AND SAFETY OF TREATING CHILDREN WITH POLYARTICULARY JUVENILE IDIOPATHIC ARTHRITIS WITH METHOTREXATE AND WITH METHOTREXATE COMBINED WITH TOCILIZUMAB
by: V. A. Kel'tsev, et al.
Published: (2015-04-01)

A retrospective evaluation of COVID-19 patients treated with Tocilizumab: who should be treated?
by: Semiha Çelik Ekinci, et al.
Published: (2021-12-01)

Asignación de los ingresos del presupuesto general del estado a los GADs municipales: periodos 2015-2022
by: Juliette Mendieta Angel
Published: (2025-04-01)

Clinical utility of the GAD-7 for detecting generalized anxiety in Quechua indigenous people
by: Nicole Caldichoury, et al.
Published: (2025-05-01)

Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation
by: E. V. Udachkina, et al.
Published: (2015-11-01)

Prognostic significance of serum interleukin-6 in severe/critical COVID-19 patients treated with tocilizumab: a detailed observational study analysis
by: Panpan Liang, et al.
Published: (2024-11-01)

A practical approach to in-hospital management of new-onset refractory status epilepticus/febrile infection related epilepsy syndrome
by: Zubeda Sheikh, et al.
Published: (2023-05-01)